GlassScriptPhysician profile
Laura G Padron
NPI 1518318047
$4,127.04
in general payments reported to CMS, 2019-2025
26 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what 89% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,100 · 2023: $1,237 · 2024: $679 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,026.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $672.04 | 2022-2025 | Evenity, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $604.27 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $425.03 | 2022-2025 | Ingrezza |
| Lilly USA, LLC | $354.02 | 2022-2025 | Kisunla, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $351.94 | 2023-2025 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $316.71 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Vanda Pharmaceuticals INC. | $189.05 | 2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $162.55 | 2023 | Rexulti, Jynarque |
| Conformis, INC. | $143.75 | 2022 | |
| Nevro Corp. | $143.01 | 2022 | |
| Inspire Medical Systems, INC. | $125.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $123.49 | 2025 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $89.55 | 2022-2023 | |
| Smith+Nephew, INC. | $67.87 | 2023 | Grafix Pl |
| Xeris Pharmaceuticals, INC. | $65.10 | 2024 | Gvoke Hypopen |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $47.72 | 2024 | Farxiga |
| Abbvie INC. | $44.35 | 2023 | |
| Exact Sciences Corporation | $39.65 | 2023-2024 | Cologuard Collection Kit |
| Corium, LLC | $38.54 | 2022 | |
| Si-Bone, INC. | $22.27 | 2023 | |
| Metacel Pharmaceuticals LLC | $21.13 | 2023 | Ozobax |
| Scpharmaceuticals INC. | $20.97 | 2023 | |
| Acella Pharmaceuticals, LLC | $15.19 | 2025 | NP Thyroid 60 |
| Philips North America LLC | $14.78 | 2025 | Respiratory |
| Pfizer INC. | $14.67 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.39 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Padron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.